Skip to content

Achieve Life Sciences ACHV CA — Tax Credit Carryforward Amount

Similar metrics at other companies

Maze Therapeutics, Inc. Common Stock logo
MAZECA — Tax Credit Carryforward Amount
$10.87M
California Resources logo
CRCCALIFORNIA — Tax credit carryforward
$21M0.0%
Beam Therapeutics logo
BEAMMA — Tax Credit Carryforward Amount
$36.4M+11.3%
Maze Therapeutics, Inc. Common Stock logo
MAZEMA — Tax Credit Carryforward Amount
$235K
California Resources logo
CRCCALIFORNIA — Net tax credit carryforwards
$8M
Novanta logo
NOVTUS — Tax Credit Carryforward Amount
$1.5M

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:TaxCreditCarryforwardAmount.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's ca — tax credit carryforward amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's CA — tax credit carryforward amount?
Achieve Life Sciences (ACHV) reported CA — tax credit carryforward amount of $1.9M in Q4 2025.
How has Achieve Life Sciences's CA — tax credit carryforward amount changed year-over-year?
Achieve Life Sciences's CA — tax credit carryforward amount decreased by 29.6% year-over-year, from $2.7M to $1.9M.
What does CA — tax credit carryforward amount mean?
The aggregate value of tax credits earned in previous periods that have not yet been utilized and are available to reduce future tax liabilities. These credits represent a valuable financial resource that enhances cash flow by lowering the effective tax burden in subsequent reporting periods.